{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:19:13Z","timestamp":1788542353371,"version":"build-2803163510"},"reference-count":0,"publisher":"Cold Spring Harbor Laboratory","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Perspect Med"],"DOI":"10.1101\/cshperspect.a041822","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:55:16Z","timestamp":1788540916000},"page":"a041822","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological Principles in the Use and Development of Antituberculosis Drugs"],"prefix":"10.1101","author":[{"given":"Geraint","family":"Davies","sequence":"first","affiliation":[{"name":"Department of Clinical Infection, Microbiology, and Immunology, University of Liverpool, Liverpool L69 7BE, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[2026,9,4]]},"container-title":["Cold Spring Harbor Perspectives in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/cshperspect.a041822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:55:16Z","timestamp":1788540916000},"score":1,"resource":{"primary":{"URL":"http:\/\/perspectivesinmedicine.cshlp.org\/lookup\/doi\/10.1101\/cshperspect.a041822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":0,"alternative-id":["10.1101\/cshperspect.a041822"],"URL":"https:\/\/doi.org\/10.1101\/cshperspect.a041822","relation":{},"ISSN":["2157-1422"],"issn-type":[{"value":"2157-1422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}